Evorel Sequi patches

Šalis: Didžioji Britanija

kalba: anglų

Šaltinis: MHRA (Medicines & Healthcare Products Regulatory Agency)

Prieinama:

DE Pharmaceuticals

ATC kodas:

G03FB05

Vaisto forma:

Not applicable

Klasė:

No Controlled Drug Status

Recepto tipas:

Never Valid To Prescribe As A VMP

Produkto santrauka:

BNF: 06040101

Pakuotės lapelis

Package Leaflet: Information for the User
EVOREL
® SEQUI TRANSDERMAL PATCHES
(ESTRADIOL/NORETHISTERONE ACETATE)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again

If you have any further questions, ask your doctor or pharmacist

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 5.
WHAT IS IN THIS LEAFLET
1. What Evorel Sequi is and what it is used for
2. What you need to know before you use Evorel Sequi
3. Safety of HRT
4. How to use Evorel Sequi
5. Possible side effects
6. How to store Evorel Sequi
7. Contents of the pack and other information
The name of your medicine is Evorel Sequi. It belongs to a group of
medicines called hormone replacement therapy (HRT).
Evorel Sequi contains two medicines:

An oestrogen (estradiol)

A progestogen (norethisterone)
They are both female hormones.
Evorel Sequi comes in a ‘memory pack’. This can be used to help
you
remember when to change your patches. Each pack contains eight
patches:

Four ‘Evorel 50’ patches marked CE50 (containing estradiol only)

Four ‘Evorel Conti’ patches marked CEN1 (containing estradiol and
norethisterone)
The hormones are spread evenly in each patch. They pass slowly into
your body through the skin.
WHAT EVOREL SEQUI IS USED FOR
Evorel Sequi is used:

For the symptoms of the menopause (see ‘What is the menopause?’).
It is only used in women who still have a womb. It is suitable for
women who have had the menopause (postmenopausal) or who are
around the time of the menopause (perimenopausal)

To prevent osteoporosis (fragile bones) in women who have had the
menopause and are most likely to have bone problems. Evorel Sequi
is only used if other m